ABSTRACT
Ochroconis gallopavum is a potentially fatal dematiaceous fungus causing opportunistic infections in immunocompromised hosts. We report the first case of disseminated O. gallopavum infection in a 13-year-old renal transplant recipient, which involved the brain, lung and spleen. He was treated with amphotericin B, itraconazole and voriconazole, a new antifungal agent first used to treat such an infection. Besides antifungal treatment, all immunosuppressive agents were stopped and automated peritoneal dialysis was resumed. The initial infection was under control with both clinical and radiological improvements after treatment. However, the patient later acquired Acremonium spp. peritonitis; he failed to respond to high-dose amphotericin B, and finally succumbed. A total of 13 reported O. gallopavum human infections, including the one described here, are reviewed. The most common site of involvement is the brain and the crude mortality rate is up to 46%. As the disease is potentially lethal in immunocompromised hosts, empirical antifungal coverage should be considered in post-renal transplant recipients with suspected brain abscess. Early biopsy of lesion for histopathological and microbiological diagnosis would be essential in managing such cases.
Subject(s)
Antifungal Agents/therapeutic use , Kidney Transplantation , Mitosporic Fungi , Mycoses/drug therapy , Opportunistic Infections/drug therapy , Adolescent , Brain/microbiology , Fatal Outcome , Humans , Immunocompromised Host , Lung/microbiology , Male , Mycoses/diagnosis , Opportunistic Infections/diagnosis , Peritoneal Dialysis , Spleen/microbiologyABSTRACT
The first case of Streptococcus bovis peritonitis associated with continuous ambulatory peritoneal dialysis (CAPD) in a 40-year-old Chinese woman suffering from systemic lupus erythematosus is reported. Streptococcus bovis is part of the normal flora in the human intestine and, less commonly, the female genital tract. Being a rare cause of peritonitis, the possible link between genital tract colonization by Streptococcus bovis and retrograde invasion of the peritoneal cavity is postulated to be the cause of continuous ambulatory peritoneal dialysis peritonitis in this patient. Since invasive Streptococcus bovis infection is associated with gastrointestinal pathology (Streptococcus bovis biotype I) and chronic liver diseases (Streptococcus bovis biotype II), identifying the biotype of Streptococcus bovis could guide treatment by indicating that further investigation of these underlying diseases is required.
Subject(s)
Peritoneal Dialysis, Continuous Ambulatory/adverse effects , Peritonitis/microbiology , Streptococcal Infections/etiology , Streptococcus bovis/isolation & purification , Adult , Female , Humans , Peritonitis/diagnosis , Peritonitis/etiology , Streptococcal Infections/diagnosis , Streptococcal Infections/microbiologyABSTRACT
We describe the first case of community-acquired Propionibacterium avidum subcutaneous tissue infection in a cirrhotic patient. A 70-year-old Chinese male with a 2-year history of hepatitis B virus-induced chronic liver failure and hemorrhoidectomy 17 months previously presented with a painful left buttock abscess, which was culture positive for P. avidum. Being a normal flora of skin with low pathogenicity, there have been only 3 case reports on P. avidum infection, all associated with surgical intervention within 2 to 6 weeks before the onset of P. avidum infection. We hereby review the literature on P. avidum summarizing
